Cannabis Science Conference East 2022: Dr. Dustin Sulak Shares Surprising Results when Treating Patients with Cannabis and Psychedelics

Patients in Australia with chronic health conditions evaluated the effects on their quality of life, changes in pain, and more after 12 months of medical cannabis.

Here, we bring you our top four recent articles covering standards in the cannabis industry, a cannabis for sleep survey, a new research and resource center at the University of Mississippi, and in-person information sessions from Metrc.

The survey included responses from over one thousand medical cannabis patients, plus an analysis of trends in the medical cannabis market.

This month’s Healer webinar explored how recent cannabis policies impact patients, parents, and more.

Industry feedback is being considered in developing pathways to make CBD accessible – and safe – to treat minor health conditions without a prescription.

Here, we bring you our top four recent news articles covering research for cannabis and ALS and autism, updates from the NCIA, and testing license applications in Alabama.